TORONTO and LONDON, ON, July 8, 2017 /CNW/ - The litigation against Boston Scientific Ltd. and Boston Scientific Corporation ("Boston Scientific") will proceed as a certified class action on behalf of women who were or are implanted with a Boston Scientific transvaginal mesh ("TVM") device for treatment of Stress Urinary Incontinence (SUI) or Pelvic Organ Prolapse (POP), and their families.
The claims against Boston Scientific have not been resolved. The allegations made by the Plaintiffs have not been proven in Court, and the Court has not made any conclusions. This information should not be considered in any way to be medical advice. Boston Scientific denies any fault or liability and continues to defend the class action.
The class action relates to certain medical devices sometimes referred to as "transvaginal mesh," "TVM," "slings" or "hammocks" manufactured by Boston Scientific. Various of these devices are used to treat SUI or POP. The class action seeks compensation for personal injuries allegedly relating to the use of such devices as well as for damages allegedly suffered by family members of women who have been implanted with these devices.
All persons resident in Canada who have been implanted with a Boston Scientific transvaginal mesh device to treat SUI or POP at any time on or before February 17, 2017 and certain of their family members are class members in the certified Boston Scientific Class Action.
The Boston Scientific Class Action does not include claims against various other manufacturers of TVM mesh devices, including AMS, Johnson & Johnson, Covidien, and Cook Medical Inc.
If you have been implanted with a transvaginal mesh but do not know the brand or type of mesh you were implanted with, you should retrieve your medical records, including your product identification tag, which typically will note what brand of mesh was used. If you need help retrieving your records, or determining which type of mesh you were implanted with, Class Counsel can assist.
Class members who do not want to be a part of a class action relevant to them must "opt out" of it. As a result of "opting out," such individuals will not be entitled to any compensation that may become available as part of the relevant class action, but they will be able to commence their own lawsuit or continue any lawsuit they have previously brought.
For more information, including on how to opt out of the class actions, see the "long form notice" available online at www.siskinds.com/transvaginal-mesh/ or by requesting it from Siskinds. Information can also be obtained in English at: 1-800-461-6166 x2367 or, in French, at: 1-418-694-2009.
SOURCE Siskinds LLP
For further information: SISKINDS LLP, 680 Waterloo Street, P.O. Box 2520, London, ON, N6A 3V8, Elizabeth deBoer, Daniel Bach, Rachel Pardy, (800) 461-6166 x2367, (519) 672-2121 x2367, email@example.com, firstname.lastname@example.org, email@example.com; SISKINDS, DESMEULES sencrl, Les Promenades du Vieux-Québec, 43, rue Buade, bur. 320, Québec, QC, G1R 4A2, Caroline Perrault, Barbara Ann Cain, (418) 694-2009, firstname.lastname@example.org, email@example.com